Baas P W, Slaughter T, Brown A, Black M M
Department of Anatomy, University of Wisconsin Medical School, Madison 53706.
J Neurosci Res. 1991 Sep;30(1):134-53. doi: 10.1002/jnr.490300115.
We have investigated the stability, alpha-tubulin composition, and polarity orientation of microtubules (MTs) in the axons and dendrites of cultured sympathetic neurons. MT stability was evaluated in terms of sensitivity to nocodazole, a potent anti-MT drug. Nocodazole sensitivity was assayed by quantifying the loss of MT polymer as a function of time in 2 micrograms/ml of the drug. MTs in the axon and the dendrite exhibit striking similarities in their drug sensitivity. In both types of neurites, the kinetics of MT loss are biphasic, and are consistent with the existence of two types of MT polymer that depolymerize with half-times of MT polymer that depolymerize with half-times of approximately 3.5 min and approximately 130 min. We define the more rapidly depolymerizing polymer as drug-labile and the more slowly depolymerizing polymer as drug-stable. The proportion of MT polymer that is drug-stable is greater in axons (58%) than in dendrites (25%). On the basis of current understanding of the mechanism of action of nocodazole, we suggest that the drug-labile and drug-stable polymer observed in both axons and dendrites correspond to two distinct types of polymer that differ in their relative rates of turnover in vivo. In a previous study, we established that in the axon, these drug-stable and drug-labile types of MT polymer exist in the form of distinct domains on individual MTs, with the labile domain situated at the plus end of the stable domain (Baas and Black, J Cell Biol 111:495-509, 1990). Because of the great difference in drug sensitivity between the drug-labile and drug-stable MT polymer, we were able to dissect them apart by appropriate treatments with nocodazole. This permitted us to evaluate the drug-labile and drug-stable polymer in terms of polarity orientation and relative content of alpha-tubulin variants generated by posttranslational detyrosination or acetylation. In both the axon and the dendrite, the modified as well as unmodified alpha-tubulins are present in both drug-labile and drug-stable polymer, but at different levels. Specifically, the modified forms of alpha-tubulin are enriched in the drug-stable MT polymer compared to the drug-labile MT polymer. In studies on MT polarity orientation, we demonstrate that in axons, MTs are uniformly plus-end-distal, whereas in dendrites, MTs are non uniform in their polarity orientation, with roughly equal levels of the MTs having each orientation.(ABSTRACT TRUNCATED AT 400 WORDS)
我们研究了培养的交感神经元轴突和树突中微管(MTs)的稳定性、α-微管蛋白组成及极性取向。根据对诺考达唑(一种有效的抗微管药物)的敏感性评估微管稳定性。通过量化在2微克/毫升该药物中微管聚合物损失随时间的变化来测定诺考达唑敏感性。轴突和树突中的微管在药物敏感性方面表现出显著相似性。在这两种神经突中,微管损失的动力学是双相的,这与存在两种以大约3.5分钟和大约130分钟的半衰期解聚的微管聚合物一致。我们将解聚较快的聚合物定义为药物不稳定型,解聚较慢的聚合物定义为药物稳定型。药物稳定型微管聚合物的比例在轴突中(58%)高于树突中(25%)。基于目前对诺考达唑作用机制的理解,我们认为在轴突和树突中观察到的药物不稳定型和药物稳定型聚合物对应于体内周转率相对不同的两种不同类型的聚合物。在先前的一项研究中,我们确定在轴突中,这些药物稳定型和药物不稳定型微管聚合物以单个微管上不同结构域的形式存在,不稳定结构域位于稳定结构域的正端(巴斯和布莱克,《细胞生物学杂志》111:495 - 509,1990)。由于药物不稳定型和药物稳定型微管聚合物在药物敏感性上有很大差异,我们能够通过用诺考达唑进行适当处理将它们分开。这使我们能够从极性取向以及由翻译后去酪氨酸化或乙酰化产生的α-微管蛋白变体的相对含量方面评估药物不稳定型和药物稳定型聚合物。在轴突和树突中,修饰的和未修饰的α-微管蛋白都存在于药物不稳定型和药物稳定型聚合物中,但水平不同。具体而言,与药物不稳定型微管聚合物相比,α-微管蛋白的修饰形式在药物稳定型微管聚合物中更丰富。在微管极性取向的研究中,我们证明在轴突中,微管均匀地正端向外,而在树突中,微管的极性取向不均匀,两种取向的微管水平大致相等。(摘要截断于400字)